Service utilization is the biggest factor behind spending variation, with prices, disease prevalence, and demographics playing smaller roles.

The root of the U.S.’s high prescription drug prices lies in its unique system, which allows pharmaceutical manufacturers to ...

We recently caught up with Nick Karls, director of compliance at Holmes Murphy and Associates, and Nathan Cassin, pharmacy ...

CVS Health’s revenues increased 4.2% in both the quarter and year, compared to the prior year driven by growth in the health ...

Aims: The use of medication in pain management currently involves empirical adjustment based on observed clinical outcome and the presence of adverse drug reactions. In this study ...

Over a span of three days, federal Customs and Border Protection (CBP) agents intercepted $4.3 million worth of cocaine in four seizures at border ...

CVS Health posted Q4 sales of $97.71B, with a 23.3% rise in Health Care Benefits revenue. Fiscal 2025 adjusted EPS guidance ...

That being said, the overall drug utilization trend in the US remains strong, and we think an improvement in GLP-1 capacity challenges should uphold our estimated low-double-digit segment growth.

The management of Leishmania donova ni (LD), responsible for fatal visceral leishmaniasis (VL), faces increasing challenges due to rising drug-unresponsiveness, leading to increasing treatment ...

Q4 2024 Earnings Call Transcript February 12, 2025 CVS Health Corporation beats earnings expectations. Reported EPS is $1.19, ...

Fixstars has a proven track record of developing efficient AI development platforms. The company recently announced the ...

Regs & Eggs provided insights into Medicare Advantage (MA), the private insurance option under Medicare, and explored both ...